Essential Pharma
An international, specialty pharmaceutical company developing clinically-differentiated, low-volume, difficult-to-manufacture medicines for chronic diseases and acute care.
Essential Pharma sells its products in more than 70 countries, supplying a portfolio of Essential medicines across multiple therapeutic areas, with a focus on the central nervous system (CNS), gastroenterology and ophthalmology.
The vast majority of Essential Pharma’s manufacturing partners that serve European patients are located in Europe.
Latest Essential Pharma News & Features
25 November 2021
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze